Streptozocin clinical trials
Also written Streptozotocin.
How each study uses Streptozocin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 7 May 1982 · ZANOSAR · NDA 050577 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2018 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 6
Gustave Roussy, Cancer Campus, Grand Paris (1) · Al-Azhar University (1) · Collaborative Group for Adrenocortical Carcinoma Treatment (1) · Emory University (1) · Hoffmann-La Roche (1) · Cambridge University Hospitals NHS Foundation Trust (1) · H. Lee Moffitt Cancer Center and Research Institute (1)
Often tested with
Tested in the same studies.
Capecitabine (3) · Bevacizumab (2) · Doxorubicin (2) · Cisplatin (2) · Fluorouracil (2) · Bolus Fluorouracil/Leucovorin Regimen (1) · Temozolomide (1) · Sitagliptin (1)
Studies
Open first, then newest update. How each study uses Streptozocin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- The Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction in Diabetic RatsCompletedPhase 4Al-Azhar UniversityNCT07083232Written as low dose Streptozotocin
- Two Chemotherapy Regimens Plus or Minus BevacizumabActive, not recruitingPhase 2Gustave Roussy, Cancer Campus, Grand ParisNCT03351296Written as Streptozocin
- Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine TumorsTerminatedPhase 2H. Lee Moffitt Cancer Center and Research InstituteNCT00609765Written as Streptozocin
- Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)CompletedPhase 3Collaborative Group for Adrenocortical Carcinoma TreatmentNCT00094497Written as Streptozotocin
- Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain NeoplasmsCompletedPhase 2Emory UniversityNCT00004688Written as streptozocin
- A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.CompletedPhase 2Hoffmann-La RocheNCT00448136Written as Streptozotocin
- Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine TumorsCompletedPhase 2Cambridge University Hospitals NHS Foundation TrustNCT00602082Written as streptozocin
Codes
What other systems call Streptozocin · ClinicalTrials.gg INT008241
- MeSH (NLM) D013311StreptozocinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 5W494URQ81STREPTOZOCINConfirmed FDA, NLM
- RxNorm 10114One source FDA
- NCI Thesaurus C845StreptozocinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D013311 | Streptozocin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 5W494URQ81 | STREPTOZOCIN | Confirmed FDA, NLM |
| RxNorm | 10114 | — | One source FDA |
| NCI Thesaurus | C845 | Streptozocin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.